Michael Yee
Stock Analyst at UBS
(3.53)
# 2,232
Out of 4,512 analysts
1323
Total ratings
46.9%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Rated: Buy | $400 → $420 | $356.70 | +17.75% | 186 | Jul 13, 2026 | |
| LLY Eli Lilly and Company | Rated: Buy | $1,250 → $1,425 | $1,156.50 | +23.22% | 7 | Jul 13, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Buy | $545 → $585 | $476.09 | +22.88% | 125 | Jul 13, 2026 | |
| ABBV AbbVie | Rated: Hold | $230 → $260 | $245.40 | +5.95% | 6 | Jul 13, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $175 → $220 | $185.52 | +18.59% | 6 | Jul 6, 2026 | |
| ORKA Oruka Therapeutics | Rated: Buy | $100 → $130 | $86.95 | +49.51% | 7 | Jul 2, 2026 | |
| ANAB AnaptysBio | Maintained: Buy | $76 | $66.24 | +14.74% | 5 | Jun 30, 2026 | |
| BIIB Biogen | Maintained: Buy | $225 | $195.58 | +15.04% | 171 | Jun 25, 2026 | |
| PFE Pfizer | Maintained: Hold | $27 | $24.26 | +11.29% | 8 | Jun 23, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $100 → $135 | $134.09 | +0.76% | 6 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $23.04 | +8.53% | 17 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $21.35 | +110.77% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.46 | +169.06% | 3 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $36.68 | +36.31% | 3 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $58.26 | +20.15% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $120.62 | +20.21% | 5 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $67.38 | -33.21% | 70 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $12.18 | +269.61% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $38.35 | +56.45% | 4 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.94 | +209.28% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $130.69 | +33.90% | 187 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $80 | $43.49 | +83.95% | 14 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $16.36 | -20.54% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $20 | $6.25 | +220.26% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $6.06 | +15.51% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $3.69 | +89.70% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $57.59 | +4.19% | 5 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $29.88 | +50.60% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $19.19 | +160.55% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $19.41 | +80.32% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $60 | $54.14 | +10.83% | 15 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.88 | +325.53% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $31.49 | -11.08% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $33.79 | +62.77% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $3.5 | $5.23 | n/a | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $8.81 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $18 | $4.01 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $8 | $3.06 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $14.65 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $55.87 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $0.7924 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $15 | $7.37 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $27.04 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $31 | $150,000.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.40 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.88 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $5.72 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $2.94 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $58.68 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $25.49 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.29 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $41.72 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $527.92 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $660.48 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $8.31 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.90 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $115.01 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $89.91 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $43.01 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $253.10 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $79.94 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $313.53 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $210.21 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.0001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $75 | $31.92 | n/a | 7 | Apr 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $18.20 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $424.86 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $423.15 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.78 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $4.62 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $73.46 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $6.04 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $129.82 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $0.0008 | n/a | 2 | Mar 20, 2012 |
Amgen
Jul 13, 2026
Rated: Buy
Price Target: $400 → $420
Current: $356.70
Upside: +17.75%
Eli Lilly and Company
Jul 13, 2026
Rated: Buy
Price Target: $1,250 → $1,425
Current: $1,156.50
Upside: +23.22%
Vertex Pharmaceuticals
Jul 13, 2026
Rated: Buy
Price Target: $545 → $585
Current: $476.09
Upside: +22.88%
AbbVie
Jul 13, 2026
Rated: Hold
Price Target: $230 → $260
Current: $245.40
Upside: +5.95%
Revolution Medicines
Jul 6, 2026
Reiterated: Buy
Price Target: $175 → $220
Current: $185.52
Upside: +18.59%
Oruka Therapeutics
Jul 2, 2026
Rated: Buy
Price Target: $100 → $130
Current: $86.95
Upside: +49.51%
AnaptysBio
Jun 30, 2026
Maintained: Buy
Price Target: $76
Current: $66.24
Upside: +14.74%
Biogen
Jun 25, 2026
Maintained: Buy
Price Target: $225
Current: $195.58
Upside: +15.04%
Pfizer
Jun 23, 2026
Maintained: Hold
Price Target: $27
Current: $24.26
Upside: +11.29%
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $100 → $135
Current: $134.09
Upside: +0.76%
Jun 16, 2026
Maintained: Buy
Price Target: $25
Current: $23.04
Upside: +8.53%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $21.35
Upside: +110.77%
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.46
Upside: +169.06%
Jun 9, 2026
Reiterated: Buy
Price Target: $50
Current: $36.68
Upside: +36.31%
Jun 3, 2026
Maintained: Buy
Price Target: $70
Current: $58.26
Upside: +20.15%
Jun 2, 2026
Maintained: Buy
Price Target: $145
Current: $120.62
Upside: +20.21%
Jun 2, 2026
Maintained: Hold
Price Target: $45
Current: $67.38
Upside: -33.21%
Jun 2, 2026
Maintained: Buy
Price Target: $45
Current: $12.18
Upside: +269.61%
May 31, 2026
Maintained: Buy
Price Target: $60
Current: $38.35
Upside: +56.45%
May 12, 2026
Maintained: Buy
Price Target: $6
Current: $1.94
Upside: +209.28%
Apr 8, 2026
Reiterated: Buy
Price Target: $175
Current: $130.69
Upside: +33.90%
Mar 27, 2026
Maintained: Buy
Price Target: $50 → $80
Current: $43.49
Upside: +83.95%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $16.36
Upside: -20.54%
Mar 5, 2026
Maintained: Buy
Price Target: $3 → $20
Current: $6.25
Upside: +220.26%
Mar 3, 2026
Maintained: Hold
Price Target: $10 → $7
Current: $6.06
Upside: +15.51%
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $3.69
Upside: +89.70%
Feb 24, 2026
Reiterated: Buy
Price Target: $60
Current: $57.59
Upside: +4.19%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $29.88
Upside: +50.60%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $19.19
Upside: +160.55%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $19.41
Upside: +80.32%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $60
Current: $54.14
Upside: +10.83%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.88
Upside: +325.53%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $31.49
Upside: -11.08%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $33.79
Upside: +62.77%
Jun 25, 2025
Maintained: Hold
Price Target: $1.5 → $3.5
Current: $5.23
Upside: n/a
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $8.81
Upside: n/a
Mar 13, 2025
Maintained: Buy
Price Target: $24 → $18
Current: $4.01
Upside: n/a
Mar 6, 2025
Maintained: Buy
Price Target: $145 → $8
Current: $3.06
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $14.65
Upside: n/a
Mar 22, 2023
Maintained: Buy
Price Target: $26
Current: $55.87
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $0.7924
Upside: n/a
Aug 10, 2021
Maintained: Hold
Price Target: $45 → $15
Current: $7.37
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $10 → $7
Current: $27.04
Upside: n/a
Dec 21, 2018
Maintained: Buy
Price Target: $40 → $31
Current: $150,000.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $1.40
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $5.88
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $5.72
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $2.94
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $58.68
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $25.49
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $5.29
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $41.72
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $527.92
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $660.48
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $8.31
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $1.90
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $115.01
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $89.91
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $43.01
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $133
Current: $253.10
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $79.94
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $313.53
Upside: n/a
Jul 28, 2016
Maintained: Buy
Price Target: $115
Current: $210.21
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.0001
Upside: n/a
Apr 20, 2016
Reiterated: Buy
Price Target: $85 → $75
Current: $31.92
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $18.20
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $424.86
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $423.15
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $3.78
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $4.62
Upside: n/a
Aug 5, 2015
Maintained: Hold
Price Target: $9
Current: $73.46
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $6.04
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $129.82
Upside: n/a
Mar 20, 2012
Maintained: Buy
Price Target: $28
Current: $0.0008
Upside: n/a